KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Capital Expenditures (2016 - 2025)

Tenet Healthcare's Capital Expenditures history spans 14 years, with the latest figure at $364.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 10.3% year-over-year to $364.0 million; the TTM value through Dec 2025 reached $1.0 billion, up 8.49%, while the annual FY2025 figure was $1.0 billion, 8.49% up from the prior year.
  • Capital Expenditures for Q4 2025 was $364.0 million at Tenet Healthcare, up from $280.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $364.0 million in Q4 2025 and bottomed at $111.0 million in Q3 2021.
  • The 5-year median for Capital Expenditures is $184.5 million (2023), against an average of $205.6 million.
  • The largest YoY upside for Capital Expenditures was 5950.0% in 2021 against a maximum downside of 57.34% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $304.0 million in 2021, then decreased by 4.61% to $290.0 million in 2022, then dropped by 28.28% to $208.0 million in 2023, then surged by 58.65% to $330.0 million in 2024, then grew by 10.3% to $364.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Capital Expenditures are $364.0 million (Q4 2025), $280.0 million (Q3 2025), and $193.0 million (Q2 2025).